Steffi Oesterreich, Ph.D.

Associate Professor of Medicine Baylor College of Medicine

Steffi Oesterreich, Ph.D.Phone: 713-798-1623
Fax: 713-798-1677
Email: steffio@breastcenter.tmc.edu

Funding
Publications
Research

Education:
Undergraduate:
1984-1989 - B.S./Masters Biochemistry, Humboldt University, Berlin
Graduate:
1989-1992 - Ph.D., Humboldt University and Max-Delbrueck Center for Molecular Medicine, Berlin-Buch

Fellowships:
1992-1996 - Postdoctoral Fellow Department of Medicine/Medical Oncology University of Texas Health Science Center at San Antonio

Honors and Awards:
1990 - HOECHST Ph.D. Award
1992 - Deutscher Akademischer Austauschdienst Fellowship (Germany), German Academic Exchange Fellowship
1993 - Postdoctoral Fellowship Grant from Susan G. Komen Breast Cancer Foundation
1994 - Research Grant from San Antonio Cancer Institute
1995 - SPORE Development Grant
1996 - Howard Hughes Institutional Grant
1998 - Howard Temin Award (K01), Career Development Grant (NIH/NCI)
1998 - Department of Defense Breast Cancer IDEA Grant
2000 - Department of Defense Concept Award
2000 - Chao Award/Baylor College of Medicine
2000 - Department of Defense Breast Cancer, Postdoctoral Fellowship Grant (Margarita Ivanova)
2000 - Department of Defense Breast Cancer, Postdoctoral Fellowship Grant (Steven Townson)
2002 - Women’s Heath Research Award (Women in Endocrinology)
2002 - American Cancer Society (ACS) Research Scholar Award (ranked #1 out of 47 application; was declined due to overlap with R01)
2003 - Department of Defense Breast Cancer, Postdoctoral Fellowship Grant (Shiming Jiang)

Professional Associations and Affiliations:
1994-present - American Association for Cancer Research
1998-present - The Endocrine Society

Brief Description of Research:
My lab has two major research interests in breast cancer. First, we are trying to understand the mechanism by which coregulators affect steroid receptor activities (e.g. chromatin remodeling, RNA processing, nuclear matrix association) Secondly, we have identified a locus on chromosome 19p13 which displays extremely high LOH in human breast cancer. We have identified candidate tumor suppressor genes in this area, and are currently proving or disproving their involvement in breast cancer development and progression